Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Emerging Company Profile

Bringing CAR T to India

How Immuneel plans to bring a $50,000 CAR T treatment to India

August 3, 2019 12:06 AM UTC

A company formed this year in Bangalore by Kiran Mazumdar-Shaw, Kush Parmar and Siddhartha Mukherjee plans to bring a CAR T therapy to cancer patients in India for about $50,000 per treatment. That cost, which includes hospital and medical expenses, would be 20 to 40 times lower than that of CAR T treatments in the U.S.

Right now, CAR T isn’t available at any price in India, and some Indian patients have traveled to the U.S. and paid more than $1 million for the treatment. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article